Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AGL Agilon Health	$1.25 +1.2%	$1.92	$0.71 ▼ $6.08	$509.74M	0.14	21.52 million shs	7.97 million shs
ARDT Ardent Health	$12.94 +2.5%	$12.43	$10.10 ▼ $20.72	$1.81B	N/A	473,121 shs	226,160 shs
CELC Celcuity	$49.22 -4.6%	$23.94	$7.57 ▼ $53.85	$2.19B	0.68	2.91 million shs	704,332 shs
PGNY Progyny	$22.74 -4.4%	$22.45	$13.39 ▼ $26.76	$2.04B	1.32	1.11 million shs	1.44 million shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AGL Agilon Health	+0.81%	+39.89%	-41.55%	-47.13%	-73.73%
ARDT Ardent Health	+2.41%	+3.77%	+16.05%	-13.62%	-26.06%
CELC Celcuity	-4.56%	-1.68%	+262.18%	+364.34%	+184.02%
PGNY Progyny	-4.37%	+4.41%	+3.36%	+7.31%	+7.37%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AGL Agilon Health	2.6128 of 5 stars	4.1	2.0	2.9	0.0	0.6
ARDT Ardent Health	3.25 of 5 stars	3.4	0.0	2.4	0.0	3.1
CELC Celcuity	1.1153 of 5 stars	1.5	2.0	2.8	3.3	0.0
PGNY Progyny	1.516 of 5 stars	1.4	2.0	3.3	2.5	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AGL Agilon Health	2.17	Hold	$3.58	187.44% Upside
ARDT Ardent Health	2.70	Moderate Buy	$19.56	51.16% Upside
CELC Celcuity	3.00	Buy	$50.60	2.80% Upside
PGNY Progyny	2.73	Moderate Buy	$24.90	9.50% Upside

Current Analyst Ratings Breakdown

Latest AGL, PGNY, CELC, and ARDT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/18/2025	CELC Celcuity	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$50.00 ➝ $66.00
8/15/2025	AGL Agilon Health	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$2.40 ➝ $1.10
8/15/2025	CELC Celcuity	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$74.00 ➝ $70.00
8/14/2025	AGL Agilon Health	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$5.00 ➝ $1.00
8/11/2025	ARDT Ardent Health	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$18.00 ➝ $15.00
8/8/2025	PGNY Progyny	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$28.00
8/8/2025	PGNY Progyny	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$26.00 ➝ $28.00
8/7/2025	ARDT Ardent Health	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$24.00 ➝ $20.00
8/6/2025	AGL Agilon Health	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Underweight ➝ Underweight	$3.00 ➝ $1.50
8/6/2025	AGL Agilon Health	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$4.00 ➝ $1.50
7/28/2025	CELC Celcuity	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$28.00 ➝ $60.00

(Data available from 8/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AGL Agilon Health	$6.06B	0.09	N/A	N/A	$0.99 per share	1.26
ARDT Ardent Health	$5.97B	0.31	$2.60 per share	4.97	$11.52 per share	1.12
CELC Celcuity	N/A	N/A	N/A	N/A	$1.05 per share	N/A
PGNY Progyny	$1.17B	1.68	$0.33 per share	68.91	$5.99 per share	3.80

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AGL Agilon Health	-$260.15M	-$0.77	N/A	N/A	N/A	-5.35%	-66.76%	-17.47%	11/6/2025 (Estimated)
ARDT Ardent Health	$210.34M	$1.81	7.15	6.60	5.58	4.11%	16.66%	5.18%	11/5/2025 (Estimated)
CELC Celcuity	-$111.78M	-$3.45	N/A	N/A	N/A	N/A	-150.07%	-64.67%	N/A
PGNY Progyny	$54.34M	$0.59	38.54	34.98	2.01	4.28%	10.69%	7.12%	N/A

Latest AGL, PGNY, CELC, and ARDT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2025	Q2 2025	CELC Celcuity	-$0.90	-$1.04	-$0.14	-$1.04	N/A	N/A
8/7/2025	Q2 2025	PGNY Progyny	$0.42	$0.19	-$0.23	$0.19	$315.70 million	$332.87 million
8/5/2025	Q2 2025	ARDT Ardent Health	$0.30	$0.52	+$0.22	$0.52	$1.54 billion	$1.65 billion
8/4/2025	Q2 2025	AGL Agilon Health	-$0.11	-$0.25	-$0.14	-$0.25	$1.47 billion	$1.39 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AGL Agilon Health	N/A	N/A	N/A	N/A	N/A
ARDT Ardent Health	N/A	N/A	N/A	N/A	N/A
CELC Celcuity	N/A	N/A	N/A	N/A	N/A
PGNY Progyny	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AGL Agilon Health	N/A	1.16	1.16
ARDT Ardent Health	0.66	2.13	2.00
CELC Celcuity	1.14	6.61	6.61
PGNY Progyny	N/A	2.70	2.70

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AGL Agilon Health	N/A
ARDT Ardent Health	N/A
CELC Celcuity	63.33%
PGNY Progyny	94.93%

Insider Ownership

Company	Insider Ownership
AGL Agilon Health	3.57%
ARDT Ardent Health	1.70%
CELC Celcuity	15.78%
PGNY Progyny	9.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AGL Agilon Health	1,076	414.42 million	399.63 million	Not Optionable
ARDT Ardent Health	24,900	143.11 million	140.67 million	Optionable
CELC Celcuity	40	42.43 million	32.77 million	Optionable
PGNY Progyny	310	85.98 million	77.90 million	Optionable

AGL, PGNY, CELC, and ARDT Headlines

Recent News About These Companies

Versor Investments LP Invests $1.05 Million in Progyny, Inc. $PGNY

1 hour ago | marketbeat.com

Connor Clark & Lunn Investment Management Ltd. Makes New Investment in Progyny, Inc. $PGNY

5 hours ago | marketbeat.com

Progyny, Inc. (NASDAQ:PGNY) Receives $24.90 Average PT from Brokerages

August 20 at 2:11 AM | americanbankingnews.com

Progyny, Inc. (NASDAQ:PGNY) Shares Purchased by Public Sector Pension Investment Board

August 19 at 4:22 AM | marketbeat.com

Deutsche Bank AG Has $5.30 Million Stock Position in Progyny, Inc. $PGNY

August 19 at 4:00 AM | marketbeat.com

Progyny (PGNY) Stock Is Up, What You Need To Know

August 18 at 12:46 AM | msn.com

Progyny, Inc. (NASDAQ:PGNY) Given Average Rating of "Moderate Buy" by Brokerages

August 18 at 2:28 AM | marketbeat.com

Fox Run Management L.L.C. Makes New Investment in Progyny, Inc. (NASDAQ:PGNY)

August 17 at 6:10 AM | marketbeat.com

Kevin K. Gordon Sells 2,500 Shares of Progyny, Inc. (NASDAQ:PGNY) Stock

August 15, 2025 | marketbeat.com

Progyny, Inc. (NASDAQ:PGNY) Director Kevin K. Gordon Sells 2,500 Shares

August 14, 2025 | insidertrades.com

5 Must-Read Analyst Questions From Progyny’s Q2 Earnings Call

August 14, 2025 | finance.yahoo.com

Cetera Investment Advisers Acquires Shares of 42,313 Progyny, Inc. (NASDAQ:PGNY)

August 14, 2025 | marketbeat.com

Analysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT), Progyny (PGNY) and Avadel Pharmaceuticals (AVDL)

August 13, 2025 | theglobeandmail.com

NeoGenomics, Progyny, Repligen, Revvity, and Waters Corporation Shares Are Soaring, What You Need To Know

August 13, 2025 | msn.com

Progyny’s Earnings Call Highlights Robust Growth and Strategic Partnerships

August 12, 2025 | msn.com

PGNY Q2 Deep Dive: Product Expansion and Client Diversification Drive Upbeat Guidance

August 12, 2025 | msn.com

Truist Financial Remains a Hold on Progyny (PGNY)

August 12, 2025 | theglobeandmail.com

1 Cash-Producing Stock with Promising Prospects and 2 We Ignore

August 12, 2025 | finance.yahoo.com

Progyny (NASDAQ:PGNY) Releases Earnings Results, Misses Estimates By $0.23 EPS

August 11, 2025 | marketbeat.com

Cantor Fitzgerald Issues Positive Forecast for Progyny (NASDAQ:PGNY) Stock Price

August 11, 2025 | americanbankingnews.com

Progyny, Inc. Just Beat EPS By 12%: Here's What Analysts Think Will Happen Next

August 10, 2025 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

AGL, PGNY, CELC, and ARDT Company Descriptions

Agilon Health NYSE:AGL

$1.25 +0.02 (+1.22%)

Closing price 08/19/2025 03:59 PM Eastern

Extended Trading

$1.22 -0.03 (-2.41%)

As of 07:26 AM Eastern

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

Ardent Health NYSE:ARDT

$12.94 +0.32 (+2.54%)

Closing price 08/19/2025 03:59 PM Eastern

Extended Trading

$12.88 -0.05 (-0.43%)

As of 07:11 AM Eastern

Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.

Celcuity NASDAQ:CELC

$49.22 -2.35 (-4.56%)

Closing price 08/19/2025 04:00 PM Eastern

Extended Trading

$49.52 +0.30 (+0.61%)

As of 07:41 AM Eastern

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, advanced or metastatic breast cancer, and metastatic castration resistant prostate cancer. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. The company was founded in 2011 and is headquartered in Minneapolis, Minnesota.

Progyny NASDAQ:PGNY

$22.74 -1.04 (-4.37%)

Closing price 08/19/2025 04:00 PM Eastern

Extended Trading

$22.63 -0.11 (-0.48%)

As of 07:00 AM Eastern

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time